hemodialysis的例句大全

Treatment modalities include drugs , diet , hemodialysis , peritoneal dialysis and renal transplantation, hemodiafiltration, plasmapheresis and hemoperfusion.

以血液透析 、 膜透析及肾移植治疗尿毒症病人;其他特殊治疗包括血液透析过滤 、 浆分离及血液灌洗等.

Treating hemodialysis patients to combat anemia corrects hemoglobin but exacerbates iron deficiency by utilizing iron stores.

治疗血液透析患者贫血虽然纠正了血红蛋白水平,却因为利用了铁储备而使铁缺乏加重.

Significant increases in both 25-hydroxy and 1, 25-dihydroxy-vitamin D levels were seen after hemodialysis mode conversion.

羟基 维生素D和 1, 25二羟维生素D3水平在血液透析模式转换后都显著上升.

We compared on-line hemofiltration to high-flux hemodialysis ( HF-HD ) in patients in a sequential manner.

我们在患者中以连续性方式比较了在线血液滤过和 高通量 血液透析 ( HF-HD ) 的疗效.

Objective To study the Incidence of acquired renal cystic disease ( ARCD ) in patients treated by hemodialysis.

目的分析血液透析患者获得性 肾囊 肿的患病率及相关因素.

Methods: Pre-hemodialysis and post-hemodialysis plasma ANP and cardiothoracic ratio ( CTR ) were evaluated in 26 chronic hemodialysis patients.

方法: 26例慢性血液透析病人在透析前后分别测定血浆ANP、 CTR 及体重.

However, he developed progressive cachexia, withdrew from hemodialysis and subsequently died.

然而他发展成恶病质, 停止血液透析,结果死亡.

Objective : To evaluate the application of expanded polytetrafluoroethylene ( ePTEE ) graftes for establishing hemodialysis access.

目的: 研究及评价人造血管建立血液透析通路的临床应用效果.

The experimental results provided a theoretical basis for evaluating the sufficiency of hemodialysis reasonably.

实验结果为合理地评价透析的充分性提供了理论根据.

Objective : To elevate the efficacy of dialysis in uremia patients treated with maintaining hemodialysis.

目的: 进一步提高尿毒症终末期维持血透患者的透析效果及生活质量.

Methods M mode and two dimensional UCG were analyzed in 38 hemodialysis cases with uremia.

方法分析38例尿毒症血透患者的M型及二维UCG和临床资料.

Objective To investigate the effects of high flux hemodialysis on serum thyroid hormone.

目的探讨高通量透析对血清甲状腺激素的影响.

Results There were no differences between intravenous and oral groups in sex, age, body weight, duration of hemodialysis, Hb values, ferritin and transferrin saturation before treatment.

结果治疗前静脉组与口服组间在男女性别比例、年龄、体重和接受治疗前维持透析时间及血红蛋白（Hb）、铁蛋白和转铁蛋白饱和度等方面均无显著差异。